AxoGen (AXGN) closed the last trading session at $13.34, gaining 0.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $17.50 indicates a 31.2% upside potential.The average comprises six short-term price targets ranging from a low of $15 to a high of $20, with a standard deviation of $1.64. While the lowest estimate indicates an increase of 12.4% from the current price level, the mo ...